Gene · 57045
Papers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,736
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and Molecular Profiles of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancers in the Era of Intensified Systemic Therapies. | Cancer Res Commun | 2026 | 42809709 | PubTator, text mining | PubMed |
| Distinct mutational landscapes for germline and somatic cancer variants in forty tumor suppressor genes. | Am J Hum Genet | 2026 | 42641600 | PubTator, text mining | PubMed |
| Whole-genome resequencing with multidimensional annotation revealed pathogenic networks in sirenomelia. | Ital J Pediatr | 2026 | 42601645 | PubTator, text mining | PubMed |
| A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease. | Front Immunol | 2026 | 42519311 | PubTator, text mining | PubMed |
| Anatomical Variability of the Transverse and Sigmoid Sinus Grooves: Implications for Skull Base Surgery. | J Neurol Surg B Skull Base | 2026 | 42404197 | PubTator, text mining | PubMed |
| Functional interaction between miR-505-3p and miR-21 contributes to GBM suppression. | Sci Rep | 2026 | 42350583 | PubTator, text mining | PubMed |
| Structural and biophysical analysis of the four CHRD domains of human chordin reveals a novel binding site for glycosaminoglycans. | J Biol Chem | 2026 | 42285510 | PubTator, text mining | PubMed |
| Precision Diagnostics in Prostate Cancer Treatment (PREDICT): A Phase II Multiarm Biomarker-Based Study (Alliance A032102). | JCO Oncol Adv | 2026 | 42232816 | PubTator, text mining | PubMed |
| Programmable Circular Single-Stranded DNA Acts as Recyclable Anti-miRNA Nucleotides to Inhibit Colorectal Cancer. | Small Methods | 2026 | 42126145 | PubTator, text mining | PubMed |
| A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. | Cancer Cell | 2026 | 42066759 | PubTator, text mining | PubMed |
| Detection of Tumor Suppressor Genes Rare Variants: Findings From Neuroblastoma Using Next-Generation Sequencing. | Pediatr Dev Pathol | 2026 | 42057469 | PubTator, text mining | PubMed |
| TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease. | Pharmacogenet Genomics | 2026 | 42011099 | PubTator, text mining | PubMed |
| Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia. | Proc Natl Acad Sci U S A | 2026 | 41955111 | PubTator, text mining | PubMed |
| Epigenetic Activity of Cancer Therapy Drugs Revealed by HeLa TI Cell-Based Assay. | Epigenomes | 2026 | 41892363 | PubTator, text mining | PubMed |
| Reduced Maintenance DNA Methylation Thresholds Enable Sensitive Reporter Assays for UHRF1 and DNMT1 Inhibition. | Adv Sci (Weinh) | 2026 | 41885367 | PubTator, text mining | PubMed |
| Genomic landscape and homologous recombination deficiency in malignant germ cell tumors reveals sex-specific therapeutic opportunities. | J Pathol | 2026 | 41831125 | PubTator, text mining | PubMed |
| Multiomics study on the tertiary lymphatic structure signature of colon cancer. | Transl Cancer Res | 2026 | 41815175 | PubTator, text mining | PubMed |
| Identification of public neoantigens with broad HLA class I coverage as candidates for off-the-shelf cancer vaccine development in colorectal cancer. | Front Immunol | 2026 | 41789101 | PubTator, text mining | PubMed |
| Succinylation: novel molecular mechanisms and prospects for targeted therapy in liver diseases. | Front Mol Biosci | 2026 | 41788628 | PubTator, text mining | PubMed |
| Exploring treatment models for oligometastatic castration-sensitive prostate cancer: evolution of therapeutic strategies. | Front Oncol | 2026 | 41768233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57045/papers